Both in Pharmaceuticals
Organon & vs Amylyx Pharmaceuticals
Over the past year OGN returned +106.4% and AMLX returned +110.8%; their daily moves had a correlation of 0.04.
OGN +106.4% AMLX +110.8%Growth of $1, one year, split-adjusted
| Metric | OGN | AMLX |
|---|---|---|
| Price | $13.85 | $28.68 |
| Market cap | $3.64B | $3.60B |
| Today | 0.00% | −1.80% |
| 1 month | +0.8% | +2.3% |
| 6 months | +3.3% | +78.5% |
| Year to date | +93.2% | +137.4% |
| 1 year | +106.4% | +110.8% |
| Revenue growth (YoY) | −1.7% | — |
| Gross margin | 55.2% | — |
| Net margin | 10.4% | — |
| P/E (TTM) | 17.1× | — |
| Price / sales | 0.6× | — |
| Net cash | -$7.10B | $250.8M |
| Dividend yield | 0.58% | — |
| Volatility (60d) | 2.9% | 112.3% |
| Short % of float | 7.2% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).